Cargando…
The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
PURPOSE: Vasoplegia is a common complication after cardiac surgery and is related to the use of cardiopulmonary bypass (CPB). Despite its association with increased morbidity and mortality, no consensus exists in terms of its treatment. In December 2017, angiotensin II (AII) was approved by the Food...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270278/ https://www.ncbi.nlm.nih.gov/pubmed/33085026 http://dx.doi.org/10.1007/s10557-020-07098-3 |